CoChat

Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse

Open access
Sawada, Masahiko, Alkayed, Nabil J., Goto, Shozo, Crain, Barbara J., Traystman, Richard J., Shaivitz, Amanda, Nelson, Randy J., Hurn, Patricia D. · 2000 · Journal of Cerebral Blood Flow & Metabolism
Cited by 157

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Recent findings in animals emphasize that experimental ischemic brain damage can be strikingly reduced by estrogen; however, the neuroprotective mechanisms are not well understood. It was hypothesized that estrogen signaling via cognate estrogen receptors (ERs) within the vasculature is an important aspect of cerebral ischemic protection in the female brain, in part by amplifying intraischemic cerebral blood flow (CBF). In the present study, the hypothesis that chronic treatment with the pure ER antagonist ICI182,780 (ICI) would increase ischemic brain damage by a blood flow-mediated mechanism was investigated. Adult C57Bl/6J mice were pretreated with either subcutaneous ICI (100 μg/day) or oil/ ethanol vehicle for 1 week before 2 hours of middle cerebral artery occlusion (MCAO) and 22 hours of reperfusion. End-ischemic regional CBF was evaluated in additional cohorts using [14 C]iodoantipyrine autoradiography. Infarction volume as measured by cresyl violet histology was greater in the striatum of ICI-treated females (70 ± 3% of contralateral striatum vs. 40 ± 12% in vehicle-treated females). Cortical injury was not enhanced relative to control animals (39 ± 6% of contralateral cortex in ICI group vs. 27 ± 8% in vehicle-treated group). Physiologic variables and ischemic reduction of the ipsilateral cortical laser-Doppler flow signal were similar between groups. Further, ICI treatment did not alter end-ischemic cortical or striatal CBF. The deleterious effect of ICI was limited to females, as there were no differences in stroke damage or CBF between male treatment groups. These data suggest that estrogen inhibits ischemic brain injury in striatum of the female by receptor-mediated mechanisms that are not linked to preservation of intraischemic CBF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004647-200001000-00015

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 157

Metadata

Authors
Sawada, M., Alkayed, N. J., Goto, S., Crain, B. J., Traystman, R. J., Shaivitz, A., Nelson, R. J., & Hurn, P. D.
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2000-01
Volume
20
Issue
1
Pages
112-118
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W1980147601
Cited by
157
References
2
FWCI
6.68
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse. https://app.cochat.ai/papers/10.1097/00004647-200001000-00015
The paper
Sawada, M., Alkayed, N. J., Goto, S., Crain, B. J., Traystman, R. J., Shaivitz, A., Nelson, R. J., & Hurn, P. D. (2000). Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1097/00004647-200001000-00015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.